Cobblestone Capital Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.45M Hold
10,598
0.12% 80
2025
Q2
$1.97M Sell
10,598
-83
-0.8% -$15.4K 0.1% 87
2025
Q1
$2.24M Sell
10,681
-600
-5% -$117K 0.12% 76
2024
Q4
$2M Sell
11,281
-281
-2% -$51.7K 0.11% 78
2024
Q3
$2.28M Buy
11,562
+484
+4% +$90.3K 0.13% 74
2024
Q2
$1.9M Sell
11,078
-98
-0.9% -$16.2K 0.12% 79
2024
Q1
$2.04M Buy
11,176
+387
+4% +$66.7K 0.13% 73
2023
Q4
$1.67M Hold
10,789
0.11% 84
2023
Q3
$1.61M Sell
10,789
-211
-2% -$31K 0.12% 83
2023
Q2
$1.48M Hold
11,000
0.1% 89
2023
Q1
$1.75M Sell
11,000
-7,427
-40% -$1.14M 0.13% 82
2022
Q4
$2.98M Buy
18,427
+2,131
+13% +$327K 0.23% 57
2022
Q3
$2.19M Buy
16,296
+13
+0.1% +$1.86K 0.18% 58
2022
Q2
$2.49M Buy
16,283
+3,036
+23% +$464K 0.19% 57
2022
Q1
$2.15M Sell
13,247
-24
-0.2% -$3.49K 0.15% 70
2021
Q4
$1.8M Sell
13,271
-20
-0.2% -$2.36K 0.12% 84
2021
Q3
$1.43M Sell
13,291
-435
-3% -$49.7K 0.1% 96
2021
Q2
$1.55M Sell
13,726
-501
-4% -$56.4K 0.1% 91
2021
Q1
$1.54M Sell
14,227
-701
-5% -$75K 0.11% 90
2020
Q4
$1.6M Buy
14,928
+80
+0.5% +$7.69K 0.12% 80
2020
Q3
$1.3M Sell
14,848
-40
-0.3% -$3.77K 0.11% 92
2020
Q2
$1.46M Sell
14,888
-313
-2% -$27.6K 0.13% 80
2020
Q1
$1.16M Hold
15,201
0.13% 85
2019
Q4
$1.35M Sell
15,201
-590
-4% -$49K 0.12% 91
2019
Q3
$1.2M Sell
15,791
-1,950
-11% -$134K 0.12% 90
2019
Q2
$1.29M Sell
17,741
-170
-0.9% -$13.4K 0.12% 91
2019
Q1
$1.44M Sell
17,911
-240
-1% -$19.6K 0.14% 77
2018
Q4
$1.67M Buy
18,151
+572
+3% +$50.3K 0.17% 70
2018
Q3
$1.66M Sell
17,579
-429
-2% -$40.7K 0.16% 71
2018
Q2
$1.67M Buy
18,008
+1,953
+12% +$191K 0.16% 68
2018
Q1
$1.52M Sell
16,055
-220
-1% -$24.2K 0.15% 71
2017
Q4
$1.57M Sell
16,275
-185
-1% -$17.4K 0.16% 75
2017
Q3
$1.46M Buy
16,460
+1,478
+10% +$113K 0.18% 69
2017
Q2
$1.09M Sell
14,982
-50
-0.3% -$3.36K 0.14% 73
2017
Q1
$979K Buy
15,032
+31
+0.2% +$1.95K 0.13% 80
2016
Q4
$939K Sell
15,001
-114
-0.8% -$6.96K 0.13% 82
2016
Q3
$953K Sell
15,115
-103
-0.7% -$6.67K 0.13% 81
2016
Q2
$942K Sell
15,218
-52
-0.3% -$3.17K 0.13% 82
2016
Q1
$872K Buy
15,270
+223
+1% +$12.4K 0.13% 87
2015
Q4
$891K Sell
15,047
-1,292
-8% -$74.4K 0.13% 88
2015
Q3
$889K Sell
16,339
-67
-0.4% -$4.36K 0.14% 87
2015
Q2
$1.1M Buy
16,406
+796
+5% +$52K 0.17% 74
2015
Q1
$914K Sell
15,610
-1,361
-8% -$82.2K 0.14% 91
2014
Q4
$1.11M Sell
16,971
-485
-3% -$30.6K 0.2% 74
2014
Q3
$1.01M Buy
17,456
+22
+0.1% +$1.22K 0.19% 75
2014
Q2
$984K Buy
17,434
+1,226
+8% +$64.3K 0.18% 80
2014
Q1
$833K Sell
16,208
-1,727
-10% -$87.3K 0.16% 88
2013
Q4
$947K Sell
17,935
-450
-2% -$22.1K 0.18% 83
2013
Q3
$822K Sell
18,385
-590
-3% -$26.2K 0.17% 83
2013
Q2
$784K Buy
+18,975
New +$830K 0.17% 87

Other funds holding ABBV

Cobblestone Capital Advisors's ABBV Position: Q3 2025 in Review

Cobblestone Capital Advisors held its AbbVie (ABBV) position steady in Q3 2025 at 10,598 shares worth $2.45M. The position accounts for 0.12% of the portfolio, ranked #80.

Cobblestone Capital Advisors first reported a position in ABBV in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.98M in Q4 2022. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Cobblestone Capital Advisors held 10,598 shares of AbbVie worth $2.45M as of Q3 2025.
  • Cobblestone Capital Advisors left its AbbVie share count unchanged in Q3 2025.
  • AbbVie made up 0.12% of Cobblestone Capital Advisors's portfolio in Q3 2025, its #80 holding.
  • Cobblestone Capital Advisors first reported a position in AbbVie in Q2 2013 and has held it in 50 quarters since.
  • Cobblestone Capital Advisors's AbbVie position peaked at $2.98M in Q4 2022.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Cobblestone Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.